No Data
No Data
JMP Securities Maintains SKYE BIOSCIENCE INC(SKYE.US) With Buy Rating, Maintains Target Price $15
Craig-Hallum Maintains SKYE BIOSCIENCE INC(SKYE.US) With Buy Rating, Announces Target Price $14
Express News | Craig-Hallum Maintains Buy on Skye Bioscience, Lowers Price Target to $14
Express News | Citizens Capital Markets Reiterates Market Outperform on Skye Bioscience, Maintains $15 Price Target
Piper Sandler Keeps Their Buy Rating on Skye Bioscience (SKYE)
Cantor Fitzgerald Maintains SKYE BIOSCIENCE INC(SKYE.US) With Buy Rating, Maintains Target Price $14
Moomoo Lily : Hello, regarding the issue you reported with the paper trading, we have verified with the relevant technical team: due to web network latency, the interface operations for simulated trading may experience some delays. We kindly ask for your patience and to wait a moment after each operation. Thank you for your feedback.
MooMamaLlama OP Moomoo Lily : @Moomoo Lily Hi Lily! thanks for the fast response with an actual answer that makes sense! We all appreciate it more than you know